Adherence to oral chemotherapy medications among gastroenterological cancer patients visiting an outpatient clinic

被引:18
作者
Hirao, Chieko [1 ]
Mikoshiba, Naoko [1 ]
Shibuta, Tomomi [1 ]
Yamahana, Reiko [1 ]
Kawakami, Aki [1 ]
Tateishi, Ryosuke [2 ]
Yamaguchi, Hironori [3 ]
Koike, Kazuhiko [2 ]
Yamamoto-Mitani, Noriko [1 ]
机构
[1] Univ Tokyo, Grad Sch Med, Div Hlth Sci & Nursing, Dept Gerontol Home Care & Long Term Care Nursing, Tokyo, Japan
[2] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan
[3] Jichi Med Univ, Dept Clin Oncol, Shimotsuke, Tochigi, Japan
关键词
gastroenterological cancer; medication adherence; oral chemotherapy medications; outpatients; ANTINEOPLASTIC AGENTS; THERAPY; NONADHERENCE; DETERMINANTS; MORTALITY; COHORT; WOMEN;
D O I
10.1093/jjco/hyx087
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: The purpose of this study was to investigate medication adherence to oral chemotherapy medications and determinants of medication non-adherence to them among gastroenterological cancer patients. Methods: A cross-sectional study was conducted on 117 consecutive, consenting, eligible patients visiting an outpatient clinic of university hospital in Japan. Good medication adherence was defined as taking 100% of the prescribed dose. Medication adherence was measured via self-report. We hypothesized that there was a significant relationship between medication non-adherence and the five factors defined by the World Health Organization: patient-related, socioeconomic-related, condition-related, treatment-related, and healthcare-system/provider-related factors. Multiple logistic regression models were used to identify factors associated with oral chemotherapy medication non-adherence. Results: The proportion of patients showing good medication adherence was 56.4%. The multiple logistic regression analysis revealed that the determinants of medication non-adherence to oral chemotherapy medications included having a history of patient-caused treatment interruptions due to worsening of symptoms (adjusted odds ratio [AOR] = 9.59, 95% confidence interval [CI] = 1.38-66.47), having diarrhea (AOR = 3.25, 95% CI = 1.13-9.34), experiencing pain (AOR = 0.17, 95% CI = 0.05-0.55), taking oral chemotherapy medication every 8 h (AOR = 5.52, 95% CI = 1.71-17.81), and diminished sense of priority for medication (AOR = 1.40, 95% CI = 1.21-1.63). Conclusions: This study suggests that many patients with gastroenterological cancer were non-adherent to oral chemotherapy medications. It might be necessary to conduct periodic screening and connect patients at a high risk of medication non-adherence to appropriate support.
引用
收藏
页码:786 / 794
页数:9
相关论文
共 50 条
  • [31] Medication adherence and patient satisfaction among hypertensive patients attending outpatient clinic in Lagos University Teaching Hospital, Nigeria
    Oluwole, Esther O.
    Osibogun, Olatokunbo
    Adegoke, Oluseyi
    Adejimi, Adebola A.
    Adewole, Ajoke M.
    Osibogun, Akin
    [J]. NIGERIAN POSTGRADUATE MEDICAL JOURNAL, 2019, 26 (02) : 129 - 137
  • [32] MISUSE OF TOPICAL CORTICOSTEROIDS AMONG PATIENTS VISITING OUTPATIENT DEPARTMENT DHQ, GUJRANWALA
    Humera, Farah
    Atiq, Zumirah
    Younas, Tanzila
    [J]. INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 5 (11): : 11533 - 11539
  • [33] Assessment of Anti-Diabetic Medications Adherence among Diabetic Patients in Sana'a City, Yemen: A Cross Sectional Study
    Othman, Gamil
    Ali, Faisal
    Ibrahim, Mohamed Izham Mohamed
    Al-Worafi, Yaser Mohammed
    Ansari, Mukhtar
    Halboup, Abdulsalam M.
    [J]. JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, 2020, 32 (21) : 114 - 122
  • [34] Validation of a scale to assess adherence to oral chemotherapy based on the experiences of patients and healthcare professionals (EXPAD-ANEO)
    Talens, Amparo
    Lopez-Pintor, Elsa
    Guilabert, Mercedes
    Canto-Sancho, Natalia
    Aznar, Maria Teresa
    Lumbreras, Blanca
    [J]. FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [35] Adherence to medication among patients with Parkinson's disease treated at a specialized outpatient unit
    Marchi, Katia Colombo
    Nisihara Chagas, Marcos Hortes
    Tumas, Vitor
    Miasso, Adriana Inocenti
    de Souza Crippa, Jose Alexandre
    Tirapelli, Carlos Renato
    [J]. CIENCIA & SAUDE COLETIVA, 2013, 18 (03): : 855 - 862
  • [36] Relationship between Health Literacy and Medication Adherence of Turkish Cancer Patients Receiving Oral Chemotherapy
    Cakmak, Huri Seval Gonderen
    Uncu, Dogan
    [J]. ASIA-PACIFIC JOURNAL OF ONCOLOGY NURSING, 2020, 7 (04) : 365 - 369
  • [37] Factors associated with adherence to chemotherapy guidelines in patients with non-small cell lung cancer
    Salloum, Ramzi G.
    Smith, Thomas J.
    Jensen, Gail A.
    Lafata, Jennifer Elston
    [J]. LUNG CANCER, 2012, 75 (02) : 255 - 260
  • [38] Evaluation of an Outpatient Pharmacy Clinical Services Program on Adherence and Clinical Outcomes Among Patients with Diabetes and/or Coronary Artery Disease
    Spence, Michele M.
    Makarem, Abir F.
    Reyes, Stacie L.
    Rosa, Lisa L.
    Nguyen, Courtney
    Oyekan, Elizabeth A.
    Kiyohara, Alan T.
    [J]. JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2014, 20 (10) : 1036 - 1045
  • [39] Oral Endocrine Therapy Agent, Race/Ethnicity, and Time on Therapy Predict Adherence in Breast Cancer Patients in a Large Academic Institution
    Hwang, Grace S.
    Paranjpe, Rutugandha
    Opsomer, Carine
    Lu, Kelvin
    Abajue, Uzoamaka
    Abughosh, Susan
    Zaghloul, Hanna
    Trivedi, Meghana, V
    [J]. CLINICAL BREAST CANCER, 2020, 20 (06) : 520 - 526
  • [40] The impact of depression medications on oral antidiabetic drug adherence in patients with diabetes and depression
    Xing, Shan
    Calip, Gregory S.
    Leow, Alex D.
    Kim, Shiyun
    Schumock, Glen T.
    Touchette, Daniel R.
    Lee, Todd A.
    [J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2018, 32 (05) : 492 - 500